Project Highlights Archives - Page 5 of 7 - MTEC | Medical Technology Enterprise Consortium

Project Highlights

Manufacture of a Settable Polymer Composite Bone Graft to Stabilize Fractures

Manufacture of a Settable Polymer Composite Bone Graft to Stabilize Fractures

mtec_admin2023-01-04T10:31:25-05:00June 7, 2021|Project Highlights|

Four-Dimensional Tactical Combat Casualty Care

Four-Dimensional Tactical Combat Casualty Care

mtec_admin2023-01-04T10:31:59-05:00May 21, 2021|Project Highlights|

BurRapid Epidural Drainage Attachment for Traumatic Brain Injury

BurRapid Epidural Drainage Attachment for Traumatic Brain Injury

mtec_admin2023-01-04T10:32:24-05:00May 7, 2021|Project Highlights|

Potential for Early Covid-19 Detection Using Fitbit Devices

Potential for Early Covid-19 Detection Using Fitbit Devices

mtec_admin2023-01-04T10:32:54-05:00April 23, 2021|Project Highlights|

MTEC Presents Annual Awards at the 6th Annual Membership Meeting

MTEC Presents Annual Awards at the 6th Annual Membership Meeting

mtec_admin2023-01-04T10:32:44-05:00April 2, 2021|Project Highlights|

Management of Sleep and Fatigue Using the SleepTank™ Smartwatch App

Management of Sleep and Fatigue Using the SleepTank™ Smartwatch App

mtec_admin2022-05-24T14:37:23-04:00March 25, 2021|Project Highlights|

Ultra-Rapid, Low-Cost Neutralizing Antibody Therapeutic for COVID-19

Ultra-Rapid, Low-Cost Neutralizing Antibody Therapeutic for COVID-19

mtec_admin2022-05-24T14:49:37-04:00March 10, 2021|Project Highlights|

Optimizing the Scalability of Evidence‐Based Behavioral Sleep Medicine Practices

Optimizing the Scalability of Evidence‐Based Behavioral Sleep Medicine Practices

mtec_admin2022-05-24T15:53:35-04:00February 17, 2021|Project Highlights|

Open Clinical Trial for the Evaluation of Novel Phospholipid Nanoparticles for the Treatment of Septic Shock

Open Clinical Trial for the Evaluation of Novel Phospholipid Nanoparticles for the Treatment of Septic Shock

mtec_admin2023-01-04T10:30:52-05:00February 1, 2021|Project Highlights|

Centivax’s Novel Engineered Antibody Neutralizes Pandemic Coronaviruses and has been Engineered for Enhanced Therapeutic Properties

Centivax’s Novel Engineered Antibody Neutralizes Pandemic Coronaviruses and has been Engineered for Enhanced Therapeutic Properties

mtec_admin2023-01-04T10:30:14-05:00January 14, 2021|Project Highlights|

Previous 456 Next